LOINCActiveObservation

LOINC Code 104132-6: HPV 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA NAA+probe (Cvx) [Interp]

104132-6 is a LOINC code used to identify HPV 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA NAA+probe (Cvx) [Interp] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Human papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA. It is commonly used with the system or sample type Cvx.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Human papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA. It is commonly used with the system or sample type Cvx.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Observation
  • Method: Probe.amp.tar

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • Human papilloma virus 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA [Interpretation] in Cervix by NAA with probe detection
  • Human papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA
  • This term was created for, but not limited in use to, the Alinity High Risk HPV test kit which detects 14 HR HPV genotypes (HPV 16, 18, 31, 33, 35, 39, 45,51, 52, 56, 58, 59, 66, and 68) is achieved through a primer mix targeting a conserved region of the HPV genomes and single stranded DNA probes. This test identifies high-risk (HR) HPV types 16, 18, 45, while reporting the concurrent detection of the other HR genotypes (31/33/52/58) and (35/39/51/56/59/66/68). This test is indicated for use in routine cervical cancer screening.
  • 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; HPV 16 & 18+45; HPV 16+18+45+31 H Risk 14 DNA; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 14; Human papillomavirus; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

HPV 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA NAA+probe (Cvx) [Interp]Human papilloma virus 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA [Interpretation] in Cervix by NAA with probe detectionHPV16+18+H Risk 14 DNA Cvx NAA+probe-ImpHuman papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNAMICROHPV 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68, CervixImp

Frequently asked questions

Code details

Code104132-6
SystemLOINC
Display nameHPV 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA NAA+probe (Cvx) [Interp]
DescriptionHuman papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA
Short nameHPV16+18+H Risk 14 DNA Cvx NAA+probe-Imp
ComponentHuman papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA
PropertyImp
TimingPt
System (specimen)Cvx
ScaleNom
MethodProbe.amp.tar
ClassMICRO
StatusACTIVE
Order/ObservationObservation

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.77
Last changed2.77

Consumer names

HPV 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68, Cervix

Part names

Human papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNAImpPtCvxNomProbe.amp.tarHPV 16 and 18 and 45 and 31+33+52+58 and 35+39+51+56+59+66+68 DNAImpression/interpretation of studyPoint in time (spot)CervixNucleic acid amplification with probe detection

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.